Search results
Council Post: 18 Reasons Why Sustainability Can Be A Strategic Business Advantage
Forbes· 1 day agoIn recent years, sustainability has become a key topic amongst individuals and businesses. As the public becomes increasingly aware of climate change and their role in reducing unnecessary waste ...
Why CEO AstraZeneca believes the drugmaker can almost double revenue by 2030
CNBC· 3 days agoAstraZeneca CEO Pascal Soriot explained in a Tuesday interview with CNBC's Jim Cramer why the...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 2 days agoThe American Society of Clinical Oncology held its annual conference in Chicago this past week,...
3 No-Brainer Stocks to Buy in June | The Motley Fool
The Motley Fool· 6 days agoYou're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and...
AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer
BioPharma Dive via Yahoo Finance· 6 days agoAstraZeneca’s immunotherapy Imfinzi helped people in the early stages of a type of lung cancer live...
AstraZeneca Gets Workers’ Covid-19 Faith Bias Suit Narrowed
Bloomberg Law· 2 days ago‘s bid to dismiss some claims from workers who asserted religious objections to its Covid-19 vaccination mandate proved successful when a federal court adopted a magistrate judge’s recommendations ...
Patient’s Dark Fantasy About Aetna Lands Him in Jail
The Daily Beast via Yahoo News· 4 days agoMany Americans loathe their health insurance providers.A majority say they have severe concerns about financial hardship due to medical bills—even with...
Astra's Enhertu breast cancer trial shows 'unprecedented' results
Reuters via AOL· 6 days ago(Reuters) -AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about...
Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support...
Morningstar· 7 days agoTempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm ...
With new Enhertu data, an ADC could overtake chemo in breast cancer
BioPharma Dive via Yahoo Finance· 6 days agoStudy participants had already received one hormone therapy and a type of drug called a CDK 4/6...